FIELD: pharmacology. SUBSTANCE: suggested pharmaceutical composition based upon fat- and triglyceride-free propofol microdrops with phospholipid covering provides constant sedative impact during prolonged periods of time at no fat overloading. Being free of nutritive substances which maintain bacterial growth, such microdrops-based preparations are bacteriostatic and bactericidal (for example self-sterilizing). EFFECT: more prolonged storage period. 9 cl, 3 tbl, 5 ex, 5 dwg
Title | Year | Author | Number |
---|---|---|---|
PROPOFOL-CONTAINING COMPOSITION WITH ENHANCED ANTIBACTERIAL EFFECT | 2001 |
|
RU2244545C2 |
COMPOSITES PRESENTING WATER-INSOLUBLE SUBSTANCE MICROPARTICLES AND METHOD OF THEIR PRODUCING | 1997 |
|
RU2186562C2 |
PROPOFOL DELIVERY SYSTEMS | 2016 |
|
RU2709812C2 |
MEDICINAL PREPARATION CONTAINING LIPOPHILIC INERT GAS | 1998 |
|
RU2204397C2 |
EMULSIONS "OIL-IN-WATER" CONTAINING PROPOFOL AND EDETATE | 1995 |
|
RU2147432C1 |
THERAPEUTIC COMPOUNDS | 2008 |
|
RU2470908C2 |
THERAPEUTIC COMPOUNDS | 2008 |
|
RU2470907C2 |
ANAESTHETIC COMPOSITION | 2011 |
|
RU2574022C2 |
PHENYLACETIC ACID SUBSTITUTED ESTERS AS SHORT-ACTING SEDATIVE SOPOROFIC AGENTS FOR SHORT-TERM ANESTHESIA AND PROVIDING SEDATIVE EFFECT, INTERMEDIATE COMPOUND, PHARMACEUTICAL COMPOSITION AND USING | 2003 |
|
RU2315037C2 |
PROPOFOL STABLE CLEAR COMPOSITIONS | 2001 |
|
RU2257892C2 |
Authors
Dates
2002-08-10—Published
1997-03-17—Filed